Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We aimed to establish an endometrial autograft model in rats that would allow for repetitive in vivo analyses of angiogenesis. Dienogest (DNG) is an orally active progestin used for the treatment of endometriosis. We investigated whether DNG would affect angiogenesis of the ectopic endometrium in our model. METHODS: Mechanically isolated endometrial fragments were transplanted into dorsal skinfold chambers in rats. We analyzed the effect of DNG on angiogenesis of the ectopic endometrium on Days 0, 2, 4, 7, 10 and 14 after transplantation using intravital fluorescence microscopy. RESULTS: The DNG-administered group showed significant suppression of angiogenesis of endometrial autografts, as indicated by the reduced size of the microvascular network and decreased microvessel density compared with those of control animals. The newly formed microvessels of the DNG-administered group showed consistently elevated diameters and centerline red blood cell velocity was decreased. Immunohistochemistry revealed a significant reduction in the level of perivascular α-smooth muscle actin within endometrial grafts of the DNG-administered group. CONCLUSIONS: DNG inhibited angiogenesis of the ectopic endometrium, with confirmed structural changes in the microvessels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sampson, J. A. (1927) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30003-x · Cited by 2,334
ESHRE guideline for the diagnosis and treatment of endometriosis
Kennedy, S., Bergqvist, A., Chapron, C., D’Hooghe, T., Dunselman, G., Greb, R., Hummelshoj, L., Prentice, A., & Saridogan, E. (2005) · Human Reproduction · doi:10.1093/humrep/dei135 · Cited by 1,584 · cited 2×
“…European Society of Human Reproduction and Embryology guidelines, gonadotrophin-releasing hormone (GnRH) agonists, danazol, gestrinone, medroxyprogesterone acetate (MPA) and combined oral contraceptives are equally effective but their side-effects and cost profiles differ (Kennedy et al., 2005).”
BackgroundStrowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., & Seitz, C. (2010) · Human Reproduction · doi:10.1093/humrep/dep469 · Cited by 381 · cited 1×
“Because DNG exhibits antiovulatory activity (Moore, 1999), antiproliferative action on endometrial cells (Okada et al., 2001) and inhibits cytokine production by endometriotic cells (Horie et al., 2005), it is expected to have a therapeutic effect against endometriosis (Strowitzki et al., 2010).”
BackgroundOlive, D. L., & Pritts, E. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450407 · Cited by 340
Danazol for pelvic pain associated with endometriosis
Farquhar, C., Prentice, A., Singla, A. A., & Selak, V. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000068.pub2 · Cited by 210 · cited 1×
“Danazol is characterized by adverse changes in lipid metabolism and androgenic adverse effects, including weight gain, edema, acne, hirsutism and oily skin, which lead to low compliance with therapy (Winkel and Scialli, 2001; Selak et al., 2007).”
BackgroundCrosignani, P. G., Luciano, A., Ray, A., & Bergqvist, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei290 · Cited by 179
Angiongenesis: a new theory for endometriosis
Healy, D. (1998) · Human Reproduction Update · doi:10.1093/humupd/4.5.736 · Cited by 173 · cited 1×
“According to this theory, angiogenesis is a major prerequisite for the initiation and progression of the disease (Healy et al., 1998).”
MethodSchlaff, W. D., Carson, S. A., Luciano, A., Ross, D., & Bergqvist, A. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.07.1315 · Cited by 168
Progestogens for endometriosis: forward to the past
Vercellini, P. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg030 · Cited by 147 · cited 3×
“…MPA is shown to impact adversely on bone mineral density, while the delay in resumption of ovulation that may follow discontinuation of this therapy is a contraindication to use in women wishing to conceive in the near future (Vercellini et al., 2003; Crosignani et al., 2006; Schlaff et al., 2006).”
BackgroundHorie, S., Harada, T., Mitsunari, M., Taniguchi, F., Iwabe, T., & Terakawa, N. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.042 · Cited by 146
Cited by
Casper, R. F. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.01.003 · Cited by 205
Vasculogenesis: A new piece of the endometriosis puzzle
Laschke, M. W., Giebels, C., & Menger, M. D. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr023 · Cited by 136
Barra, F., Scala, C., & Ferrero, S. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1461840 · Cited by 100
Szubert, M., Suzin, J., Duechler, M., Szulawska, A., Czyz, M., & Kowalczyk-Amico, K. (2014) · Reproduction, Fertility and Development · doi:10.1071/rd12258 · Cited by 36
“It has been reported that after the use of dienogest or GnRH analogues, VEGF concentrations drop significantly (Meresman et al. 2003; Katayama et al. 2010).”
BackgroundMabrouk, M., Paradisi, R., Arena, A., Del Forno, S., Matteucci, C., Zannoni, L., Caprara, G., & Seracchioli, R. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1405932 · Cited by 17
Metadata
- Authors
- Katayama, H., Katayama, T., Uematsu, K., Hiratsuka, M., Kiyomura, M., Shimizu, Y., Sugita, A., & Ito, M.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-09-02
- Volume
- 25
- Issue
- 11
- Pages
- 2851-2858
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2137191456
- Cited by
- 68
- References
- 15
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.